cholesterol drug

Heart on futuristic podium with neon lighting
MedTech

NewAmsterdam partners with AI-based Caristo Diagnostics

Caristo Diagnostics will play a major role in an upcoming study of NewAmsterdam Pharma’s cholesterol-lowering drug candidate obicetrapib.
Natalie Missakian Oct 15, 2025 9:30am
maze unravel find navigate direction path

Editas plans to target high cholesterol with gene editing

Sep 2, 2025 1:46pm
Coral reef sea underwater

Merck's oral PCSK9 makes waves with 3rd phase 3 win

Sep 2, 2025 9:35am
Coral reef sea underwater

Merck's oral PCSK9 inhibitor leader reduces cholesterol in ph. 3

Jun 9, 2025 9:00am
roadmap hurdles

Verve posts clean PCSK9 editor profile, teeing up Lilly decision

Apr 14, 2025 7:00am
heart cardiovascular check up stethescope

NewAmsterdam shares sign drug improves cardiovascular outcomes

Dec 10, 2024 8:48am